First experience of magnetically levitated extracorporeal left ventricular assist device for cardiogenic shock in China

被引：6

作者：

Li, Ping ^{[1
]}

Wu, Long ^{[1
]}

Dong, Nianguo ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan, Peoples R China

来源：

ESC HEART FAILURE | 2022年 / 9卷 / 02期

关键词：

Maglev; Extracorporeal ventricular assist device; Cardiogenic shock; MEMBRANE-OXYGENATION; METAANALYSIS; SURVIVAL; OUTCOMES;

D O I：

10.1002/ehf2.13769

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report the first case of an investigational maglev extracorporeal ventricular assist device (extra-VAD) use in China for a patient with cardiogenic shock post-coronary artery bypass surgery. There were no extra-VAD devices available for clinical use in China. The patient was successfully supported for 9 days and recovered to hospital discharge. Throughout the support, the patient's haemodynamic and haematologic parameters demonstrated good patient recovery and no device-related complications were observed. Our results encourage extra-VAD use in short-term to mid-term bridging the cardiogenic shock patients in China and potentially other developing countries for both clinical and health economic benefits.

引用

页码：1471 / 1473

页数：3

共 6 条

[1] Thoratec CentriMag for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency: A Systematic Literature Review and Meta-Analysis of Observational Studies [J].